2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Mesenchymal Stem Cells and Cellular Transplantation

93.7 - Allogenic Epineural Tube Nerve Gap Repair with Bone Marrow Stromal Cells (BMSC) Supportive Therapy Yields Comparable Outcomes to Autograft Repair

Presenter: Amanda, Mendiola, ,
Authors: Brzezicki G., Jundzill A., Mendiola A., Klimczak A., Gatherwright J., Siemionow M.

ALLOGENIC EPINEURAL TUBE NERVE GAP REPAIR WITH BONE MARROW STROMAL CELLS (BMSC) SUPPORTIVE THERAPY YIELDS COMPARABLE OUTCOMES TO AUTOGRAFT REPAIR

MESENCHYMAL STEM CELLS AND CELLULAR TRANSPLANTATION

G. Brzezicki, A. Jundzill, A. Mendiola, A. Klimczak, J. Gatherwright, M. Siemionow
Plastic And Reconstructive Surgery, Cleveland Clinic, Cleveland/UNITED STATES OF AMERICA

Body: Introduction Limited source of autografts available for transfer and donor site morbidity after harvesting the grafts warrants further research on new methods of nerve repair. Allogenic epineural tube supported with BMSC may be a valuable alternative for nerve gap repair. The aim of this study is to assess the outcome of peripheral nerve repair with allogenic tube supported with BMSC. Methods 18 fully allogenic [ACI (RT1a) to LEW (RT1l)] 2 cm epineural tubes were transplanted into sciatic nerve gaps in 3 groups without immunosupression: Group 1 the tube was filled with saline control, Group 2 supported with isogenic BMSC [LEW (RT1l)], Group 3 allogenic BMSC [ACI (RT1a)]. Before transplantation 3.5-4 x106 BMSC were stained with PKH-dye to evaluate engraftment of cells. 6 additional autograft repairs were performed as a control group. Assessment methods included clinical examination: pinprick (PP) and toe-spread (TS) test at 6, 12 and 24 weeks post-transplant, Somatosensory Evoked Potentials (SSEP), Gastrocnemius Muscle Index (GMI), histomorphometry, immunostaining for NGF and Laminin B2 at 24 weeks. Results Macroscopic observation revealed nerve regeneration through the tube without any signs of rejection. 6 and 12 weeks post transplantation there were no differences between experimental groups in TS and PP evaluation. At 24 weeks saline group had tendency to lower TS scores, however no differences were noted in PP. Significantly higher GMI were observed in autograft group compared to Group 1 and Group 2 compared to Group 1 and 3. There were no significant differences between groups in SSEP latencies and amplitudes. Autograft group had thicker myelin and nerve fibers than Group 1 and 2 (Figure 1). Saline group had significantly higher axonal density than autograft group and ACI BMSC group. Immunostaining confirmed presence of BMSC expressing NGF in the tube up to 24 weeks (Figure 2). Laminin B2 expression was comparable in all groups. Conclusions Allogenic epineural tube alone provides neuropermissive environment for nerve regeneration without immunosupression, however local BMSC therapy supports maturation of nerve fibers. Allogenic epineural tube supports nerve regeneration by high expression of Laminin B2. NGF expression by BMSC potentiates this effect. Allogenic epineural tube/BMSC construct may be a future alternative to autograft repair, with comparable outcomes.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada